Experience sharing is critical for women in science
Sharing experiences with future generations is key to moving science and biotechnology forward. As a female leader of a biotechnology company, Dr. Bridget Martell, CEO of Artizan Biosciences, shares her experiences and perspectives with ScienceBoard. Read More
Elektrofi receives contract under the Defense Health Agency
Elektrofi has entered into a contract with the Defense Health Agency Small Business Innovation Research Program within the U.S. Department of Defense to explore the company's platform formulation technology for the delivery of prefilled, high-dose formulations for the rapid deployment of antibody treatments for COVID-19 and pandemic preparation. Read More
Focus on drug-manufacturing optimization prioritizes patient health
As medical innovations and therapeutics advance rapidly and dramatically increase in scale, there is a critical need for manufacturing processes that can keep up with this pace. This often calls for updates, overhauls, and collaboration among companies to maintain such a high standard of production. Read More
Capri EGM acquires R&D build-to-suit for National Resilience
Real estate investment manager Capri EGM has funded and acquired a newly constructed, state-of-the-art lab and R&D facility for National Resilience. Read More
Cantex collaborates with Harvard's Wyss Institute
Cantex Pharmaceuticals has secured a global license from Harvard University's Office of Technology Development to further develop its oral, small-molecule inhibitor, azeliragon, into a treatment for inflammatory lung diseases including COVID-19. This new global license from Harvard bolsters Cantex's existing robust azeliragon composition of matter patent and other intellectual property portfolios covering azeliragon. Read More
Moderna, Thermo Fisher Scientific partner on COVID-19 manufacturing
Moderna and Thermo Fisher Scientific have entered into a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the U.S. of Spikevax, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in its pipeline. Read More
Dante Labs partners with Renato Dulbecco Foundation
Dante Labs is partnering with the Renato Dulbecco Foundation to deliver more personalized therapies in rare diseases, oncology, and COVID-19. Read More
Eli Lilly's bebtelovimab receives EUA for mild-to-moderate COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Eli Lilly's antibody bebtelovimab, which demonstrates neutralization against the omicron COVID-19 variant. Read More
Pfizer, BioNTech provide update on COVID-19 vaccine
Pfizer and BioNTech extended their rolling submission to the U.S. Food and Drug Administration to amend the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine to include children six months old through four years of age. Read More
mRNA-based therapeutics pioneer innovation in the biopharmaceutical industry
In the age of COVID-19, many novel therapeutics have been brought to the forefront, most notably mRNA-based therapies. This technology has been used in two of the most prominent COVID-19 vaccines currently available in the U.S. under the U.S. Food and Drug Administration emergency use authorization. As a result, some companies are expanding mRNA-based technology to apply it to other therapies while further strengthening its use in vaccines. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter